Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001185603 | SCV001351854 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001481908 | SCV001686266 | likely benign | Li-Fraumeni syndrome | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001185603 | SCV002582572 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002290491 | SCV002582874 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001185603 | SCV002651020 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001481908 | SCV004823788 | likely benign | Li-Fraumeni syndrome | 2023-05-15 | criteria provided, single submitter | clinical testing |